Literature DB >> 22073493

Primary immunodeficiency update and newborn screening.

Mercedes C Amado1.   

Abstract

Most newborns with severe combined immunodeficiency (SCID) appear normal. Hematopoietic stem cell transplant within the first three months of life increases survival and decreases medical costs. Newborn screening measuring T cell receptor excision circles (TREC), a by product of T cell maturation, offers the opportunity for early diagnosis before infections and failure to thrive occur. The Secretary of Health and Human Services recently recommended addition of TREC to newborn screening, enabling prompt diagnosis and effective management of SCID.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22073493      PMCID: PMC6188393     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  17 in total

1.  State, federal efforts under way to identify children with "bubble boy syndrome".

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

2.  Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.

Authors:  Laurie A Myers; Dhavalkumar D Patel; Jennifer M Puck; Rebecca H Buckley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Statewide newborn screening for severe T-cell lymphopenia.

Authors:  John M Routes; William J Grossman; James Verbsky; Ronald H Laessig; Gary L Hoffman; Charles D Brokopp; Mei W Baker
Journal:  JAMA       Date:  2009-12-09       Impact factor: 56.272

4.  Why newborn screening for severe combined immunodeficiency is essential: a case report.

Authors:  Mehdi M Adeli; Rebecca H Buckley
Journal:  Pediatrics       Date:  2010-07-05       Impact factor: 7.124

5.  Development of population-based newborn screening for severe combined immunodeficiency.

Authors:  Kee Chan; Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2005-02       Impact factor: 10.793

6.  Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Authors:  Alessandro Aiuti; Federica Cattaneo; Stefania Galimberti; Ulrike Benninghoff; Barbara Cassani; Luciano Callegaro; Samantha Scaramuzza; Grazia Andolfi; Massimiliano Mirolo; Immacolata Brigida; Antonella Tabucchi; Filippo Carlucci; Martha Eibl; Memet Aker; Shimon Slavin; Hamoud Al-Mousa; Abdulaziz Al Ghonaium; Alina Ferster; Andrea Duppenthaler; Luigi Notarangelo; Uwe Wintergerst; Rebecca H Buckley; Marco Bregni; Sarah Marktel; Maria Grazia Valsecchi; Paolo Rossi; Fabio Ciceri; Roberto Miniero; Claudio Bordignon; Maria-Grazia Roncarolo
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

7.  PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years.

Authors:  M S Hershfield
Journal:  Clin Immunol Immunopathol       Date:  1995-09

8.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

Authors:  Salima Hacein-Bey-Abina; Alexandrine Garrigue; Gary P Wang; Jean Soulier; Annick Lim; Estelle Morillon; Emmanuelle Clappier; Laure Caccavelli; Eric Delabesse; Kheira Beldjord; Vahid Asnafi; Elizabeth MacIntyre; Liliane Dal Cortivo; Isabelle Radford; Nicole Brousse; François Sigaux; Despina Moshous; Julia Hauer; Arndt Borkhardt; Bernd H Belohradsky; Uwe Wintergerst; Maria C Velez; Lily Leiva; Ricardo Sorensen; Nicolas Wulffraat; Stéphane Blanche; Frederic D Bushman; Alain Fischer; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

9.  Development of a routine newborn screening protocol for severe combined immunodeficiency.

Authors:  Mei W Baker; William J Grossman; Ronald H Laessig; Gary L Hoffman; Charles D Brokopp; Daniel F Kurtycz; Michael F Cogley; Thomas J Litsheim; Murray L Katcher; John M Routes
Journal:  J Allergy Clin Immunol       Date:  2009-05-31       Impact factor: 10.793

10.  Vaccine-acquired rotavirus in infants with severe combined immunodeficiency.

Authors:  Niraj C Patel; Paula M Hertel; Mary K Estes; Maite de la Morena; Ann M Petru; Lenora M Noroski; Paula A Revell; I Celine Hanson; Mary E Paul; Howard M Rosenblatt; Stuart L Abramson
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.